Skip to content

Modification to Whole PTH (1-84) Specific Immunochemilluminometric (ICMA) Assay Kit, Model 3KG002

by Scantibodies Laboratory, Inc.

510(k) K060420

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK060420 Date1 Mar 2006ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
CEW
Device Class
Class II
Regulation
21 CFR Part 862.1545
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 6 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Whole PTH (1-84) ICMA assay is an in vitro diagnostic test used to quantify parathyroid hormone levels in human plasma samples. The device utilizes an immuno-chemiluminometric assay principle to detect the hormone.

This assay kit is supplied as a modification to an existing device and is intended for laboratory use. It is a Class II device with FDA 510(k) clearance K060420, granted on March 1, 2006, with a decision of Substantially Equivalent. The device is regulated under product code CEW and is not specified as single-use or reusable.

Other devices from Scantibodies Laboratory Inc.

See all devices from Scantibodies Laboratory Inc. →

Questions

AI-generated answers, 6 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the purpose of the Whole PTH (1-84) ICMA assay kit?

    The Whole PTH (1-84) ICMA assay kit is an in vitro diagnostic test used to quantify parathyroid hormone levels in human plasma samples. It utilizes an immuno-chemiluminometric assay principle to detect the hormone for laboratory use.

  • How is the Whole PTH (1-84) ICMA assay kit supplied?

    The assay kit is supplied as a modification to an existing device. It is intended for laboratory use and is not specified as single-use or reusable. The device is supplied with all necessary components for performing the immuno-chemiluminometric assay.

  • What is the regulatory status of the Whole PTH (1-84) ICMA assay kit?

    The device is a Class II device with FDA 510(k) clearance K060420, granted on March 1, 2006, with a decision of Substantially Equivalent. It is regulated under product code CEW and is not specified as single-use or reusable.

  • What are the specifications of the Whole PTH (1-84) ICMA assay kit?

    The assay kit is designed for laboratory use and utilizes an immuno-chemiluminometric assay principle to detect parathyroid hormone levels in human plasma samples. The device is a modification to an existing device and is not specified as single-use or reusable.